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Abstract 
The aim of this study was to evaluate the effects of early postpartum PGF2α treatment on reproductive performance 
in dairy cows synchronized with targeted breeding and natural mating after voluntary waiting period. In this 
experiment , 120 cows were assigned to three groups irrespective of presence or absence of luteal tissue. Cows in PG-
14 group were treated with PGF2α from day 14 postpartum, cows in PG-28 group were treated with PGF2α from 
day 28 postpartum and cows in PG-42 group were not treated with PGF2α until the end of voluntary waiting period 
(d 42). After day 42 postpartum, cows in three groups were treated with PGF2α within 14-day intervals until natural 
mating after voluntary waiting period. Recorded reproductive parameters included days to first heat, days to first 
mating, days open, service per conception, conception rate, percentage of repeat breeder animals and pregnancy 
loss. Early PGF2α treatment from day 14 postpartum significantly decreased days to first estrus (34.9 ± 0.74, P < 
0.003), days to first mating (62.35 ± 1.53, P < 0.04), days open (117.23 ± 3.1, P < 0.001) and service per conception 
(1.9 ± 0.09, P < 0.02); and PG-14 group presented increased conception rate (52.5%, P < 0.05). The proportion of 
repeat breeder syndrome tended to be affected by treatment with PGF2α from day 14 postpartum. In conclusion, 
treatment of cows with PGF2α from day 14 postpartum improved reproductive performance.  
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Resumo 
O objetivo do presente trabalho foi avaliar os efeitos do tratamento pós-parto precoce com PGF2α sobre o 
desempenho reprodutivo de vacas leiteiras sincronizadas para reprodução controlada por monta natural após o 
período de espera voluntário. Neste experimento, 120 vacas foram distribuídas em três grupos independentes da 
presença ou ausência de corpo lúteo. Vacas no grupo PG-14 foram tratadas com PGF2α a partir do 14o dia pós-
parto, vacas do grupo PG-28 foram tratadas com PGF2α a partir do 28o dia pós-parto e as vacas do grupo PG-42 não 
foram tratadas com PGF2α até o final do período de espera voluntário (d42). Após o 42o dia pós-parto as vacas dos 
três grupos foram tratadas com PGF2α com intervalos de 14 dias até a monta natural após o período de espera 
voluntário. Os registros dos parâmetros reprodutivos incluíram: dias para o primeiro estro, dias para a primeira 
cobertura, dias em aberto, serviços por concepção, taxa de concepção, percentagem de animais repetidores de cios e 
as perdas de gestações. O tratamento precoce com PGF2α, a partir do 14o dia pós-parto reduziu significativamente 
os dias para o primeiro estro (34,9 ± 0,74, P < 0,003), dias para a primeira cobertura (62,35 ± 1,53, P < 0,04), dias em 
aberto (117,23 ± 3,1, P<0,001) e o número de serviços por concepção (1,9 ± 0,009, P < 0,02); e o grupo PG-14 
apresentou um acréscimo na taxa de concepção (52,5%, P < 0,05). A proporção da síndrome de vacas repetidoras de 
cios tendeu a ser afetada pelo tratamento com PGF2α a partir do 14o dia pós-parto. A conclusão obtida foi que o 
tratamento das vacas com PGF2α a partir do 14o dia pós-parto melhorou o desempenho reprodutivo dos animais. 
Palavras-chave: PGF2α. Pós-parto. Reprodução controlada. Monta natural.  
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Introduction 
The events that must be completed after 
parturition before a cow is likely to conceive again are 
uterine involution, regeneration of the endometrium, 
elimination of bacterial contamination from the 
uterus, and the return of ovarian cyclical activity 
(SHELDON et al., 2008). Favorable uterine involution 
is very important for the next reproductive cycle of 
postpartum cows, and influences subsequent fertility 
(THATCHER et al., 2006). Most postpartum dairy 
cows are invaded by opportunistic and pathogenic 
bacteria within the first 21 days postpartum 
(THATCHER et al., 2006; SHELDON et al., 2008). In 
most instances, cows eliminate these bacteria from the 
uterus by approximately three weeks postpartum; 
however, some do not, and the presence of these 
bacteria predisposes these cows to reduced 
reproductive performance (HENDRICKS et al., 2006).  
The early postpartum uterus produces large 
amounts of the F-series prostaglandins (GUILBAULT 
et al., 1984), as reflected by high peripheral 
concentrations of 13, 14-dihydro-15-keto-
prostaglandin F-metabolite (PGFM). The 
concentration of PGFM increases in plasma prior to 
parturition, due to the release of prostaglandin F2 
alpha (PGF2α). Secretion of PGF2α leads, in most 
cows, to a decrease in progesterone 1–2 days before 
parturition and to the final regression of the CL. A 
major increase in PGFM in blood plasma occurs 1–4 
days postpartum, followed by a slow decrease to a 
basal level by day 15. This decrease has been found to 
be associated with uterine regression and a reduction 
in the rate of involution (EDQVIST et al., 1978).  
There are conflicting reports on the effectiveness of 
exogenous PGF2α to increase the rate of uterine 
involution, cause evacuation of bacterial 
contamination from the uterus, and subsequently 
improve conception rate (YOUNG et al., 1984; 
ETHERINGTON et al., 1988; ARCHBALD et al., 
1990; RISCO et al., 1994). These reports examined the 
use of PGF2α on either one or two occasions between 
12 and 40 days postpartum, without regard to the 
presence of a functional corpus luteum (CL). After 
PGF2α administration 25–32 days postpartum, 
improved fertility has been observed in cattle 
(PANKOWSKI et al., 1995). Peters (1989) concluded 
that enhancement of the reproductive performance of 
cows treated with PGF2α after parturition is not due 
to a direct effect on pituitary ovarian function 
(PETERS, 1989). The presence of a CL did not 
influence the outcome of prostaglandin treatment 
(GLANVILL; DOBSON, 1991) and the effects of 
PGF2α administered at day 26 postpartum on the 
uterine involution and reproductive performance is 
independent of progesterone level at the time of 
treatment (MCCLARY et al., 1989; BONNETT et al., 
1990; RISCO et al., 1994). 
It was reported that exogenous PGF2α would be 
more consistently effective in increasing motility and 
evacuation of bacterial contamination of the 
postpartum uterus if it was administered when there is 
a CL in the ovary (NAKAO et al., 1997; 
HIRSBRUNNER et al., 2003). Some research has 
shown no improvement in pregnancy rates 
(MORTIMER et al., 1984), but other workers have 
shown significant improvements in the pregnancy 
rates of cows treated 14–28 days postpartum with a 
single injection of PGF2α (YOUNG et al., 1984). 
Benmrad and Stevenson (1986) reported that 
postpartum administration of prostaglandin F2α 
reduces the number of services required per 
conception (BENMRAD; STEVENSON, 1986). 
In PGF2α-based breeding programs, often referred 
to as Target Breeding or Monday Morning Breeding 
Programs, groups of cows are injected with PGF2α as 
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they reach the voluntary waiting period (VWP) and 
are bred to detected estrus for the next three to five 
days (DEJARNETT, 2015). Cows not bred after the 
first injection are re-treated with PGF2α 14 days later 
and observed for estrus for another five days. A set-up 
PGF2α injection 14 days before the first breeding 
injection will help to improve estrous response at this 
first breeding opportunity. The hypothesis of the 
present study was that repeated administration of 
PGF2α in the immediate postpartum period would 
increase the reproductive performance after natural 
mating in postpartum dairy cows synchronized with 
targeted breeding. Therefore, we aimed to determine 
the effect of administration of PGF2α in the 
immediate postpartum period on reproductive 
performance in dairy cows synchronized with targeted 
breeding and naturally mated at estrus after a VWP.  
 
Materials and methods 
Animals and study farm 
The study was conducted from March 2014 to 
March 2015 on 138 Holstein cows from a commercial 
dairy herd in suburb of Semnan, Iran. Cows were no 
seasonal, year-round calvers and milked thrice daily. 
Cows were housed in free-stall barns and fed a total 
mixed ration (TMR) three times daily. The TMR was 
formulated to meet or exceed requirements for 
lactation. Cows were blocked according to parity and 
milk production. The VWP was 42 days, and cows 
detected in estrus were naturally mated. Heat 
detection was done by visual observation.  
 
Study design 
Each animal in each block was randomly assigned 
to one of the following three groups. PGF2α treatment 
in PG-14 group (n = 40) started on d 14 postpartum, 
in PG-28 group (n = 40) started on d 28 postpartum 
and in PG-42 (n = 40) cows only received PGF2α 
treatment after the end of VWP (42d). Cows in three 
groups were treated with PGF2α every 14 days starting 
on day 14, 28 or 42 and continued until natural mating 
after VWP. Intramuscular injection of 5 mL 
prostaglandin F2α (Lutalyse; Pfizer Animal Health, 
New York, NY, USA, containing 25mg dinoprost) was 
administered to each cow. 
Animals were excluded or withdrawn from this 
experiment for any of the following reasons: failure to 
complete the treatment scheme, animals with retained 
fetal membrane or dystocia which later experienced 
metritis and were treated with systemic antibiotics 
and/or PGF2α, animals that underwent surgery 
(correction of displaced abomasum), animals placed 
in the hospital barn that received systemic antibiotic 
therapy during the study period, animals assigned as 
controls (PG-42) that were treated with PGF2α during 
VWP and animals culled from the herd or died during 
the study period. 
 
Mating, pregnancy diagnosis, pregnancy 
loss, and reproductive performance 
All cows were mated after VWP and examined for 
pregnancy by ultrasonography on days 32 ± 3 after 
mating. Detection of an embryonic vesicle with a 
viable embryo in which heartbeat was visualized, was 
used as an indicator of pregnancy. Pregnant cows were 
palpated again per rectum 30 days later (62 ± 3 after 
mating) for confirmation of pregnancy. Recorded 
reproductive parameters were days to first estrus, days 
to first mating, days open, service per conception, 
conception rate, the percentage of repeat breeder 
animals and pregnancy loss in each group. 
 
Statistical analysis 
At the end of the assay, the data were organized in 
excel sheets and then parametric variables between 
three treatments were analyzed using ANOVA test 
using General Linear Models Procedure (GLM PROC) 
by SAS (ver: 9.1/ 2005) software. Differences between 
treatments were tested for significance using the 
Duncan’s Multiple Range test. A P value < 0.05 was 
considered significant. For non-parametric variables 
(conception rate and repeat breeder), 
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NONPAR1WAY Procedure was used to compare 
treatments with Kruskal-Wallis tests. 
 
Results  
There were no significant differences between the 
treatment groups in the distribution of parity and milk 
yield. The total number of the cows enrolled in the 
present study was 138. Eighteen cows were excluded 
from the study for noted reasons. Therefore, 120 cows 
remained available for data analysis. Data were 
obtained for 40 cows in PG-14 group, 40 cows in PG-
28 group and 40 cows in PG-42 group.  
Treatment with PGF2α starting on day 14 
postpartum significantly reduced the postpartum 
interval to first estrus and the number of services per 
conception (Table 1). Also intervals to first mating and 
days open were significantly reduced in the cows of the 
PG-14 group by ~10 days and ~18 days, respectively 
(Table 1). The prevalence of repeat breeder syndrome 
was not affected with treatment but it tended to be 
affected by PG-14 (10% vs. 15% and 17.5%, P = 0.09, 
PG-14, PG-28 and PG-42, respectively). No pregnancy 
loss was detected in the experimental groups (Table 2); 
therefore, pregnancy rates in each group were 
identical on days 32 and 62 after mating. Conception 
rate in PG-14 group was 12.5 and 10 incremented 
compared to PG-28 and PG-42 groups, respectively (P 
= 0.01; Table 2). 
 
 
 
Table 1 – Effect of different regimens of treatment with prostaglandin F2α during postpartum injection on reproductive 
performance in three experiments – Semnan, Iran – 2015 
  Treatments    
 PG-141 (n = 40) PG-282 (n = 40) PG-423 (n = 40) P sig 
Reproductive Parameters Mean ± SE4 CV Mean ± SE CV Mean ± SE CV   
Days to 1st estrus 34.9a ± 0.74 13 37.35b ± 0.70 11 38.75b ± 0.89 14 0.003 * 
Days to 1st mating 62.35a ± 1.53 15 72.33b ± 3.69 21 71.28b ± 3.32 29 0.04 * 
Days Open 117.23a ± 3.1 16 134.63b ± 2.37 10 137.93b ± 3.24 14 < 0.001 ** 
Service per conception 1.9a ± 0.09 23 2.5b ± 0.14 30 2.35b ± 0.02 24 0.02 * 
1 Prostaglandin F2α treatment was started from d 14 postpartum. 2 Prostaglandin F2α treatment was started from d 28 
postpartum. 3 There was no treatment during voluntary waiting period (first 42 days postpartum). 4 Standard Error. a,b Values 
within a row with different superscripts are different (P < 0.05). *(P < 0.05), **(P < 0.001) 
 
 
Table 2 – Effect of three experiments on conception rate, pregnancy loss and repeat breeder – Semnan, Iran 
– 2015 
  Treatments  
Items PG-141 (n = 40) PG-282 (n = 40) PG-423 (n = 40) 
Pregnancy/mating at 32 ± 3 d of mating 52.5% (21/40)a 40% (16/40)b 42.5% (17/40)b 
Pregnancy/mating at 62 ± 3 d of mating 52.5% (21/40)a 40% (16/40)b 42.5% (17/40)b 
Pregnancy loss 0% (0/21)a 0% (0/16)a 0% (0/17)a 
Repeat breeder 10% (4/40)a* 15% (6/40)a* 17.5% (7/40)a* 
1 Prostaglandin F2α treatment was started from d 14 postpartum. 2 Prostaglandin F2α treatment was started 
from d 28 postpartum. 3 There was no treatment during 42 days of voluntary waiting period. a,b Values within 
a row with different superscript letters are significantly different (P < 0.01). *Values within a row with 
different superscript letters tended to be significant different (0.05 > P < 0.1) 
 
 
Discussion  
The objective of this study was to evaluate the 
effects of immediate postpartum PGF2α treatment on 
reproductive performance in dairy cows synchronized 
with targeted breeding program and naturally mated 
after VWP. In the present study, treatment with 
PGF2α from day 14 postpartum has shown beneficial 
effects in cows naturally mating. 
The rationale for using PGF2α in the absence of a 
CL (days 14 postpartum) in our study was based on 
the results of previous research suggesting that PGF2α 
has direct effects on the uterus (LINDELL; KINDAHL, 
1983; RISCO et al., 1994), and can resolve uterine 
infections in cows without a CL (DEL VECCHIO et 
al., 1994). It has been shown that exogenously 
administered PGF2a can increase uterine PGF2α and 
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luteal leukotriene B4 (LTB4) secretion 
(HOEDEMAKER et al., 1992), and that LTB4 can 
enhance chemotaxis and antibody-independent cell-
mediated cytotoxicity. It has been reported that 
PGF2α promotes uterine involution and reduces the 
risk of uterine infection (SLAMA et al., 1993). 
Collectively, this information suggested that 
exogenous PGF2α could have beneficial effects on the 
postpartum uterus in the absence of a CL. Further, it 
was considered that administration of PGF2α after the 
development of a CL would lead to luteolysis, remove 
the suppressive effect of progesterone on the uterus, 
enhance uterine defenses and mitigate the 
immunosuppressive effects of progesterone (LEWIS, 
2004).  
In the present study, earlier postpartum PGF2α 
treatment (day 14; PG-14 group) affected the moment 
of first estrus and first mating. However, PGF2α 
treatment after day 28 postpartum (PG-28 and PG-42) 
did not affect these parameters. Longer duration and 
greater magnitude of postpartum peripheral plasma 
13,14-dihydro-15-keto-prostaglandin F-metabolite 
(PGFM) concentrations have been related to faster 
uterine involution (LINDELL et al., 1982) and may 
favor earlier resumption of ovarian activity; and 
Lindell et al. (1982) speculated that uterine synthesis 
of PGF2a increases uterine muscle tone, promoting 
uterine involution and, also, that delayed involution is 
associated with inadequate synthesis of PGF2a. It 
seems that earlier first estrus and first mating after 
PGF2α treatment in PG-14 group was probably due to 
direct effect of PGF2α on the uterus, and resolving of 
uterine infection in cows without a CL in early 
postpartum. Results from this experiment support 
previous findings that a single intramuscular injection 
of PGF2α in the early postpartum period (between 7 
and 28 days) reduced the postpartum interval to 
conception (YOUNG et al., 1984; BENMRAD; 
STEVENSON, 1986) and had a positive effect on 
reproductive performance (WHITE; DOBSON, 1990; 
PANKOWSKI et al., 1995; NAKAO et al., 1997; 
SCHOFIELD et al., 1999). These studies did not 
compare the effect of earlier PGF2α injection (around 
day 14 of VWP) and late PGF2α injection (around day 
28 of VWP) in VWP but our results showed that 
earlier PGF2α treatment was better than late PGF2α 
treatment. The shorter postpartum interval to PGF2α 
administration was associated with an earlier first 
postpartum estrus. However, Hendricks et al. (2006) 
demonstrated that repeated administration of PGF2α 
on days 7, 14, 22 and 35 in the early postpartum period 
had no effect on days to first service and the 
probability of pregnancy at first insemination. Also, 
Salasel and Mokhtari (2011) reported that treatment 
with PGF2α had no effect on days to first estrus and 
days to first artificial insemination at day 20 
postpartum (SALASEL; MOKHTARI, 2011). Kindahl 
et al. (1976) and McClary et al. (1989) found that the 
time to first ovulation was unaffected by PGF2α 
treatment, and Young et al. (1984) reported no effect 
on the postpartum interval to first service. 
Kasimanickam et al. (2005) reported that PGF2α 
treatment of cows with subclinical endometritis at 20 
to 33 days postpartum did not reduce the median days 
to first service (KASIMANICKAM et al., 2005). In this 
regard, unlike our results that achieved from normal 
postpartum dairy cows, Kasimanickam et al. (2005) 
reported that there was no benefit in a routine 
injection of PGF2α to dairy cows with abnormal 
puerperium in the period 14 to 28 days after calving 
when rebreeding commenced more than 70 days after 
calving (GLANVILL; DOBSON, 1991). It is speculated 
that the different VWP had influenced the time to first 
artificial insemination in different studies and can be 
a reason for different results. It seems that in the case 
of prolonged VWP, such parameters should not be 
considered while evaluating the use of PGF2α in the 
early postpartum period. Treatment with PGF2α also 
affects days to first estrus and mating due to its direct 
ecbolic effect on the uterus, and positive effect on 
uterine muscle tone and involution rate (LINDELL; 
KINDAHL, 1983).  
The interval from parturition to involution of the 
uterus has been reported as lasting from 26 to 52 days 
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(MORROW et al., 1969). The length of this interval 
increases with parity, decreases with an increase in 
milk production (BUCH et al., 1955). Cows in this 
experiment were paired for milk yield and parity to 
minimize these confounding effects. Therefore, it is 
speculated that days to first estrus and days to first 
mating are influenced by parity and milk production, 
which is not similar in all studies.  
Our study showed that pregnancy/mating rate on 
day 32 was improved with PGF2α administration on 
day 14 postpartum. Other studies showed that 
conception rate was not influenced with PGF2α 
treatment before VWP (SCHOFIELD et al., 1999). 
Conversely, Salasel and Mokhtari (2011) reported that 
conception rate and pregnancy loss were improved 
with administration of PGF2α on day 21 postpartum.  
In the present study, postpartum treatment with 
PGF2α from day 14 decreased the mean of days open. 
Salasel and Mokhtari (2011) showed that days open 
was decreased (32days) with using PGF2α in day 21 
postpartum. However, Schofield et al. (1999) 
indirectly demonstrated that treatment with PGF2α in 
early postpartum decreases days open. They reported 
that treatment of dairy cows with PGF2α at day 21 
postpartum reduced the postpartum interval to first 
service by seven to nine days; therefore, days open was 
also affected. On the other hand, another study 
reported that interval to first postpartum insemination 
of treated cows with PGF2α was like control group 
(without PG2α treatment in early postpartum) and 
within a range of 130–134 days postpartum 
(HENDRICKS et al., 2006). Our result showing 
improvement of days open may have been mediated 
through a direct action of PGF2α on uterine smooth 
muscle causing myometrial contractions of the uterus, 
in addition to the apparent advancement of ovulation. 
This may enhance uterine involution as well as 
cleaning the uterine lumen of residual products 
resulting from parturition, or subsequently 
established uterine pathogens.  
In this study, mean service per conception in PG-
14 group was lower than PG-28 and PG-42 groups (1.9 
vs. 2.5 and 2.35, respectively). It is speculated that 
reduced number of services per conception was the 
outcome of frequency of estrous cycles before first 
mating. Other study similarly shown that the mean 
services per conception were improved (1.64 vs. 2.33) 
by postpartum treatment with PGF2α on Days 14 to 
16 (MCCLARY et al., 1989). Salasel and Mokhtari 
(2011) also reported that postpartum treatment with 
PGF2α improved the mean service per conception in 
cows with calving and puerperal traits. Benmard and 
Stevenson (1986) showed that administration of 
PGF2α at 20 to 24 days postpartum reduced services 
per conception by 26% to 41%, especially in cows with 
puerperal problems (BENMARD; STEVENSON, 
1986). 
According to the results obtained in the current 
study, injections of PGF2α on day 14 postpartum 
reduced the prevalence of repeat breeder syndrome. In 
agreement with our results, two injections of PGF2α 8 
h apart on day 20 postpartum reduced the prevalence 
of repeat breeder syndrome in cows with calving and 
puerperal traits (SALASEL; MOKHTARI, 2011). 
However, there are some differences in studies which 
have investigated the use of PGF2α at the postpartum 
period in dairy cows and there is difference between 
day of PGF2α injection in studies and different studied 
did not compare effect of early or late PGF2α injection 
in VWP on reproductive performance. Also, the type 
of PGF2α used in these studies, type of animals 
selected for these studies, protocols used for and the 
timing of treatment were different. Therefore, some 
authors reported that PGF2α treatment in postpartum 
period had no beneficial effect on fertility 
(ARCHBALD et al., 1990; GLANVILL, DOBSON, 
1991; HENDRICKS et al., 2006), but others showed 
that it improved reproductive performance (YOUNG 
et al., 1984; MELENDEZ et al., 2004; 
KASIMANICKAM et al., 2005). Therefore, the 
difference in the results of these studies is somewhat 
due to different study designs. According to above 
mentioned dissimilarities, it is suggested that further 
consideration should be given to selection and timing 
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of optimum PGF2α treatment protocol for cows with 
different kinds of abnormalities in the postpartum 
period. 
In conclusion, despite the cost, the administration 
of PGF2α in the immediate postpartum period 
improves reproductive performance in dairy cows 
submitted to target breeding program, only when 
PGF2α treatments starts earlier on day 14 postpartum 
compared to days 28 or 42. 
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